Glaucoma Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024". Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration and Diabetic Retinopathy in the aging population and increase in Research & development for the improvement of novel entity are some of the key factors which boost the Global Glaucoma Drugs Market.
Glaucoma is inherited diseases that damage the eye’s optic nerve and can result in optic damage and vision loss. However, with early detection and treatment, you can often protect your eyes against serious vision loss. It is often related to a buildup of pressure inside your eye. Glaucoma be likely to hereditary and may not show up until later in life. The increased pressure, called intraocular pressure can damage the optic nerve. If the damage continues, Glaucoma can cause fatal vision loss. Lack of treatment for Glaucoma can cause total permanent blindness within a few years. There are two different types of glaucoma i.e., Open-Angle Glaucoma and Acute Angle-Closure Glaucoma. The most common type is Open-Angle Glaucoma with fewer common types including Closed-Angle Glaucoma and Normal-Tension Glaucoma. Open-Angle Glaucoma develops slowly over time and there is no pain. Closed-Angle Glaucoma can present slowly or quickly. The sudden presentation may cause severe eye pain, blurred vision, mid-dilated pupil, redness of the eye and nausea. Acute Angle-Closure Glaucoma is a less common form of Glaucoma that can rapidly impair vision. Glaucoma can be cured with eye drops, injections, oral pills, laser treatment and surgery. Though Glaucoma cannot be treated completely but the disease progression can be controlled with the help of available drugs like blockbuster drugs.
Global Glaucoma Drugs Market has been segmented on the basis of Disease Indication, Drug Class, End users, Surgery and Geography. On the basis of Disease Indication Global Glaucoma Drugs Market is classified as Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and other. On the basis of Drug Class Global Glaucoma Drugs market is segmented into Prostaglandin Analogs (PGAS), Alpha Agonist, Beta Blockers, Cholinergic Drugs and others. On the basis of end users Global Glaucoma Drugs market is segmented into Hospitals and Home users. On the basis of surgery Global Glaucoma Drugs market is classified into into Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery, Peripheral Iridotomy and Others.
The regions covered in Global Glaucoma Drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/57
Key Players for Global Glaucoma Drugs Market Reports –
Global Glaucoma Drugs market reports cover prominent players like Aerie Pharmaceuticals, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc., Pfizer Inc., Merck & Co., Fera Pharmaceuticals, Teva Pharmaceuticals, Allergan, pSivida Corp, Icon Bioscience Inc., Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, ACADIA Pharmaceuticals, Acorn Biomedical, Acucela, Aerie Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Altacor, Amakem Therapeutics, Astellas Pharma, Bausch & Lomb, Bayer, BioAxone Biosciences, Can-Fite BioPharma, D.Western Therapeutics Institute, Envisia Therapeutics, Inotek Pharmaceuticals, Kowa Pharmaceutical, Lexicon Pharmaceuticals, Mati Therapeutics, NEMUS Bioscience, Nicox, Novartis, Ocata Therapeutics, Ocular Therapeutix, Ohr Pharmaceutical, OphthaliX, Otsuka Pharmaceutical Company, Peregrine Ophthalmic, Perrigo Company, Pfizer, Regeneron Pharmaceuticals, R-Tech Ueno, Sandoz, Santen Pharmaceutical Company, Senju Pharmaceuticals, Sucampo Pharmaceuticals, Sylentis, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Wakamoto Company and Lightmed.
Global Glaucoma Drugs Market Dynamics –
Rising prevalence of diabetes, increasing geriatric population as well as expanding health care spending is the major key driver for Global Glaucoma Drugs Market. Along with growing obese population will boost the market growth in the upcoming years. Development of new drugs & devices and drug therapy focused upon Intraocular Pressure (IOP) are some notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.
However, low efficacy of generic drugs restricts the Ophthalmologists in prescribing generic drugs over branded drugs in developed countries. It has been seen that generic drugs show different bioequivalence with change in temperature. In addition to this bottle's material, shape & size, delivery dose, drop size and different pH also affects the efficacy of generic drug, ensuing more number of side effects and longer duration treatment.
The easy availability of medical insurance coverage for treatment and diagnosis is likely to create worthwhile opportunities for the key players operating in the Global Glaucoma Drugs Market in the coming years.
The advancements in drug development and the investigation of a large number of regulatory healthcare reforms, favoring development of methods for the improved diagnosis and treatment of chronic pain, will help the Global Glaucoma Drugs Market along a promising growth path in the future.
Global Glaucoma Drugs Market Regional Analysis –
According to the research report, the North America is expected to show a strong growth in the next few years, due to the rising geriatric population and the availability of options for treatment of eye disorders such as cataract, age-related muscular degeneration, glaucoma, diabetic retinopathy, and others. Furthermore, the increasing awareness among patients regarding Glaucoma and the introduction of favorable reimbursement policies are some of the chief factors predicted to fuel the growth of the North America glaucoma therapeutics market in the next few years.
Moreover, Europe is expected to show a healthy growth rate during the forecast period. The considerable growth of this region can be attributed to the growing demand for topical eye drops and expected launch of the combination medication. Asia Pacific is projected to witness fastest growth with a profitable CAGR during the forecast period due to high clinical requirements, rising income, accessibility of effective treatment methods and rising awareness about early diagnosis in emerging countries. It was stated that around two-third of the population in the Asia Pacific region are blind or vision impaired. Besides, development of various novel technologies in developing markets such as China & India is projected to expand the healthcare facilities.
Request for Methodology Report @ https://brandessenceresearch.com/requestMethodology/PostId/57
Key Benefits for Global Glaucoma Drugs Market Reports –
Global Glaucoma Drugs Market Segmentation –
By Disease Indication Analysis
Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, Others
By Drug Class Analysis
Prostaglandin Analogs (PGAS), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors, Others
By Surgery Analysis
Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery, Peripheral Iridectomy, Others
By End-users Analysis
Hospitals, Home users, Others
North America (US., Canada), Europe (UK., France, Germany, Italy), Asia Pacific (China, Japan, India, Southeast Asia), Latin America (Brazil, Mexico), Middle East and Africa (GCC, Africa, Rest of Middle East and Africa)
Buy Detail Report @ https://brandessenceresearch.com/Checkout?report_id=57
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org